Table 1.
Clinicopathologic, cytogenetic, and molecular features of 27 patients with acute myeloid leukemia.
| Patient ID |
Sex | Age (year) |
2022 WHO Classification | BM Blasts (%) |
FLT3-ITD Mutation |
NPM1 Mutation |
EVI1 Overexpression |
MLL-PTD |
WT1 Mutation |
|---|---|---|---|---|---|---|---|---|---|
| AML1 | F | 40 | AML with NPM1 mutation | 49 | + | + | - | - | - |
| AML2 | F | 35 | AML with maturation | 55 | - | - | - | - | - |
| AML3 | F | 58 | AML with maturation | 52 | - | - | - | - | - |
| AML4 | F | 45 | AML with RUNX1::RUNX1T1 | 33 | - | - | - | - | + |
| AML5 | F | 51 | AML with maturation | 79 | - | - | + | + | - |
| AML6 | M | 23 | AML with RUNX1::RUNX1T1 | 25 | - | - | - | - | - |
| AML7 | M | 61 | AML with maturation | 53 | - | - | - | + | + |
| AML8 | M | 51 | AML with maturation | 72 | - | - | - | - | + |
| AML9 | M | 37 | AML with maturation | 86 | - | - | - | - | + |
| AML10 | M | 31 | AML with maturation | 63 | + | - | - | - | + |
| AML11 | M | 61 | AML with maturation | 41 | - | - | - | - | + |
| AML12 | F | 65 | AML with maturation | 57 | - | - | - | + | + |
| AML13 | M | 31 | AML with maturation | 58 | - | - | - | - | + |
| AML14 | M | 18 | Acute monocytic leukemia | 71 | + | - | - | + | + |
| AML15 | F | 31 | AML with MECOM rearrangement | 59 | - | - | + | - | + |
| AML16 | F | 38 | AML with NPM1 mutation | 53 | - | + | - | - | + |
| AML17 | F | 62 | Acute myelomonocytic leukemia | 85 | - | - | - | - | - |
| AML18 | F | 60 | Acute myelomonocytic leukemia | 44 | - | - | - | - | - |
| AML19 | M | 36 | AML with maturation | 41 | - | - | + | + | - |
| AML20 | M | 67 | AML with maturation | NA | - | - | + | + | - |
| AML21 | F | 54 | AML with KMT2A rearrangement | NA | - | - | - | - | - |
| AML22 | M | 83 | AML with maturation | 86 | + | + | - | - | - |
| AML23 | F | 60 | AML with maturation | 54 | - | + | - | - | + |
| AML24 | M | 52 | AML with NPM1 mutation | 41 | - | + | - | - | + |
| AML25 | F | 50 | APL with PML::RARA | 66 | - | - | - | - | + |
| AML26 | M | 54 | AML with maturation | 27 | - | - | - | + | + |
| AML27 | F | 35 | APL with PML::RARA | 79 | - | - | - | - | - |
AML, acute myeloid leukemia; BM, bone marrow; F, female; M, male; NA, not available; +, present; -, absent.